Uncategorised - European Medical Journal

Concerns Raised Over Pancreatitis Risk from GLP-1 Drugs

Although GLP-1 medicines are generally well tolerated, there have been reports of rare but serious cases of acute pancreatitis.

Handshake on green background

Bayer’s Stefan Oelrich elected as new EFPIA President

Stefan Oelrich has been newly elected President of the EFPIA, as new leadership calls for action to restore Europe’s global leadership in pharma innovation.

Review of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) 2025

THE ANNUAL world-leading course in interventional cardiology, the European Association of Percutaneous Cardiovascular Interventions…

EuroPCR 2025: Making Quantum Leaps in Interventional Cardiology

THIS YEAR’S EuroPCR 2025 reached a record-breaking attendance of more than 12,000 participants and introduced a new ‘Complexity…

Cardiac Imaging Innovations at EuroPCR 2025

THE EUROPEAN Association of Percutaneous Cardiovascular Interventions (EuroPCR) 2025 Annual Meeting, held from the 20th–23rd May at the…

Updates in Pleural Disease Management

Learn about changes and trends in the management of pneumothorax, malignant pleural effusion, and the optimal use…

How to Diagnose and Treat Food Allergies

Food allergies affect up to 10% of the population in the USA and have been increasing in prevalence over the last 2–3 decades…

ESHRE 2025: Impact of Advanced Paternal Age on Donor Egg IVF Success

Even when using young donor eggs, IVF outcomes are significantly poorer in men over 45, new data from ESHRE 2025 reveal.

Paediatric Cardiac Arrest: Epinephrine Route Choice Does Not Impact Survival

Find out how epinephrine administration routes impact survival in paediatric cardiac arrest—explore the latest evidence now.

Video vs In-Person: Breast Cancer Risk Models Compared

A new randomized study finds that integrating breast density and polygenic risk scores (PRS) into breast cancer risk assessments significantly alters individual risk estimates and may influence future screening strategies.